Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Borgers, J.S.W.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(5)
+
-
Availability
Open access
(4)
+
-
Metadata Only
(1)
+
-
Creation Date
2022
(3)
+
-
Faculty
Leiden University Medical Center (LUMC)
(3)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(3)
+
-
Scholarly Publications
(2)
+
-
Author
Borgers, J.S.W.
(5)
+
-
Haanen, J.B.A.G.
(5)
+
-
Berkmortel, F.W.P.J. van den
(3)
+
-
Blank, C.U.
(3)
+
-
Kapiteijn, E.
(3)
+
-
Veldt, A.A.M. van der
(3)
+
-
Aarts, M.J.B.
(2)
+
-
Boers-Sonderen, M.J.
(2)
+
-
Burgers, F.H.
(2)
+
-
Dijk, M. van
(2)
+
-
Eertwegh, A.J.M. van den
(2)
+
-
Groot, J.W.B. de
(2)
+
-
Hospers, G.A.P.
(2)
+
-
Houdt, W.J. van
(2)
+
-
Kessels, R.
(2)
+
-
Korse, C.M.
(2)
+
-
Piersma, D.
(2)
+
-
Schumacher, T.N.
(2)
+
-
Suijkerbuijk, K.P.M.
(2)
+
-
Thienen, J.V. van
(2)
+
-
Vreugdenhil, G.
(2)
+
-
Wouters, M.W.J.M.
(2)
+
-
Show more
Language
en
(5)
+
-
Search results
(1 - 5 of 5)
show grid
show list
save search
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
Seasonal variation of anti-PD-1 outcome in melanoma-Results from a Dutch patient cohort
Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19